Skip to main content
DAEWOONG PHARMA logo

DAEWOONG PHARMA — Investor Relations & Filings

Ticker · 069620 ISIN · KR7069620003 KO Manufacturing
Open in API
Filings indexed 380 across all filing types
Latest filing 2025-04-02 Major Shareholding Noti…
Country KR South Korea
Listing KO 069620

About DAEWOONG PHARMA

http://crm.daewoong.co.kr/eng/main

Daewoong Pharma is an R&D-centric pharmaceutical company specializing in the development, manufacturing, and commercialization of medical products. The company's portfolio encompasses prescription drugs, with a focus on gastrointestinal and endocrine therapies, alongside biologics, healthcare products, and active pharmaceutical ingredients (APIs). A core tenet of its business model is 'Open Collaboration,' actively seeking partnerships with academic and industry entities to foster innovation. Daewoong Pharma's research efforts are directed towards breakthrough therapies, utilizing advanced drug delivery technologies and expertise in biologics. The company also offers integrated formulation and manufacturing services, supporting partners from initial development to commercial production.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by the National Pension Service regarding their holdings in Daewoong Pharmaceutical. This type of filing is a standard regulatory disclosure for major shareholders (10% or more) to report changes in their share ownership, which falls under the category of 'Major Shareholding Notification'.
2025-04-02 Korean
[기재정정]사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) which is the Korean equivalent of an Annual Report (10-K). It contains detailed financial and operational data, including production capacity, facility status, and subsidiary information for the fiscal year ending 2024.12.31. It is a comprehensive report rather than an announcement or a summary. FY 2024
2025-04-01 Korean
투자판단관련주요경영사항
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Daewoong Pharmaceutical regarding the termination of a technology export contract (licensing agreement) with CS Pharmaceuticals. It details the nature of the contract termination, the impact on the company, and the date of the decision. This type of disclosure regarding material business events, specifically contract terminations, falls under general regulatory announcements in the context of the provided categories.
2025-03-28 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (정기주주총회결과) for Daewoong Pharmaceutical. It details the approval of financial statements, dividend declarations, and the election of board members (directors). This falls under the category of Declaration of Voting Results & Voting Rights Announcements, as it reports the outcome of the shareholder meeting.
2025-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details specific changes to the company's board of directors, including the appointment of a new outside director and the resignation/term expiration of others. This falls directly under the category of board and management changes.
2025-03-26 Korean
[기재정정]사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a '사업보고서' (Business Report) for Daewoong Pharmaceutical, which is the Korean equivalent of an Annual Report (10-K). It covers the fiscal year ending December 31, 2024, and includes detailed financial information, corporate governance, management discussion, and audit-related disclosures. Although it mentions '정정' (correction) in the header, it is a comprehensive annual filing rather than a simple announcement or notice. FY 2024
2025-03-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.